Latest Breaking News On - Seishi katsumata - Page 1 : comparemela.com

PRISM, ONO to co-create development candidate for oncology target

PRISM, ONO to co-create development candidate for oncology target
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.

Dai takeharaSeishi katsumataOno discovery research

PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono

PRISM BioLab will utilize PepMetics®, innovative small molecules that mimic three-dimensional structures of alpha-helix and beta-turns of peptides for drug discovery against oncology target selected by Ono

Dai takeharaSeishi katsumataEisai co ltdOno pharmaceutical co ltdBiolab co ltdDiscovery research of onoOhara pharmaceuticals co ltdExecutive director

Ono Pharmaceutical : Enters into a Collaboration Agreement with PRISM BioLab to Generate Novel Drug Candidates in the Oncology Area

Osaka, Japan, April 25, 2024 - Ono Pharmaceutical Co., Ltd. today announced that it has entered into a drug discovery collaboration agreement with PRISM BioLab to generate novel.

Dai takeharaSeishi katsumataToichi takinoOno pharmaceutical co ltdMono pharmaceuticalsBiolab head officeDiscovery research of onoHead officeExecutive director

Ono Pharmaceutical : Announcement on Changes of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers -April 05, 2024 at 12:07 am EDT

　Osaka, Japan, April 5, 2024 - Ono Pharmaceutical Co., Ltd. announced that it has decided changes of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers at the.

Shusaku nagaeSeishi katsumataHiromu habashitaToshihiro tsujinakaShinji takaiTakehiro yamadaToichi takinoAkira takadaHirokazu kitadaMasaki itoYasuo hishiyamaKiyoaki idemitsuTatsuya okamaotoGyo sagaraSatoshi takahagiMasayuki tanigawa